Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/28/2026

1. SPCX
2. NVDA
3. MIRM
4. USO
5. LLY
6. KOD
7. INCY
8. CRCL
9. SHEL
10. META

Go back to Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2020 Financial Results

Fulcrum Therapeutics Inc. (FULC) Misses Q1 EPS by 6c

May 13, 2020 7:06 AM EDT

Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q1 EPS of ($0.81), $0.06 worse than the analyst estimate of ($0.75).

Despite these unprecedented times, the first quarter was a period of important progress for Fulcrum and the fundamentals of our business remain strong, said Robert J. Gould, Ph.D.,... More